Effects of Pregabalin as a Neural Pathway Inhibitor for the Treatment of Resistant Subacute and Chronic Cough: A Pilot Clinical Trials Study.

Seyed Hasan AdeliAbolfazl Mohammad BeigiSajjad AhmadpourMohammad Amin HabibiMohammad Reza PashaeiEhsan SharifipourMansoureh ShakeriAkram Asghari

Published in: Reviews on recent clinical trials (2023)

Pregabalin increases the quality of life in patients with subacute and chronic cough resistant to standard treatment and increases the rate of recovery in these patients.

Keyphrases

clinical trial
end stage renal disease
newly diagnosed
neuropathic pain
chronic kidney disease
ejection fraction
randomized controlled trial
combination therapy
patient reported outcomes
postoperative pain
replacement therapy